Search Login Register

Oculopharyngeal Muscular Dystrophy Summary

Description: An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.

Also Known As: Muscular Dystrophy, Oculopharyngeal; Dystrophies, Oculopharyngeal Muscular; Dystrophy, Oculopharyngeal Muscular; Muscular Dystrophies, Oculopharyngeal; Oculopharyngeal Muscular Dystrophies

Networked: 141 relevant articles (1 outcomes, 7 trials/studies) for this Disease

Key Drugs and Agents for Oculopharyngeal Muscular Dystrophy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Poly(A)-Binding Protein II : 1 study in 46 results : IBA
  2. Poly(A)-Binding Proteins (Poly(A)-Binding Protein) : 1 study in 27 results : IBA
  3. Ubiquitin : 1 study in 4 results : IBA
  4. Creatine Kinase (Creatine Phosphokinase) : 1 study in 2 results : IBA
  5. Lactic Acid : 1 study in 1 result : FDA 4 Generic
  6. Amyloid beta-Peptides : 1 study in 1 result : IBA
  7. Collagen : 1 study in 1 result : IBA
  8. desmuslin (synemin) : 1 study in 1 result : IBA
  9. tranilast (N 5') : 1 study in 1 result : IBA
  10. polyalanine : 44 results : IBA
Show All >>

Diseases Related to Oculopharyngeal Muscular Dystrophy

  1. Facial Pain (Myofacial Pain)
  2. Inclusion Body Myositis
  3. Muscular Diseases (Myopathy)
  4. Muscular Dystrophies (Muscular Dystrophy)
  5. Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
Show All >>

Key Therapies for Oculopharyngeal Muscular Dystrophy

Efficacy Chart >>
  1. Rhytidoplasty (Facelift) : 1 outcome in 1 result
  2. Transplantation (Transplant Recipients) : 1 study in 2 results
  3. Denervation : 1 study in 1 result
  4. Airway Management : 1 result
  5. Fundoplication : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.